19 reports

  • CHAPTER III BIOPHARMACEUTICALS INDUSTRY ASSESSMENTS
  • Chapter III

CSF is one important biopharmaceuticals in China.

  • Biopharmaceutical
  • Pharmaceutical
  • Beijing Sihuan Pharmaceutical Co., Ltd.
  • Beijing SL Pharmaceutical Co Ltd
  • Beijing Tri-Prime Genetic Engineering Co., Ltd.

GenSci' s profitability has been ranked No. ## among Chinese biopharmaceutical companies.

  • Biochemical
  • Biopharmaceutical
  • Biotechnology
  • Pharmaceutical
  • Beijing Tri-Prime Genetic Engineering Co., Ltd.

These newly launched products currently average revenue of $##M in 2017 but are expected The fourth wave includes large-cap players such as Shire, Novo Nordisk, and Eli Lilly, but also many small-cap bio/ pharma companies or private bio/ pharma companies with only

  • Biopharmaceutical
  • Biosimilar
  • AbbVie Inc.
  • Alexion Pharmaceuticals, Inc.
  • Kyowa Hakko Kirin Co., Ltd.

The auto exports exceeded over ## million each year.

  • Biopharmaceutical
  • Blood Disease
  • Leukemia
  • Therapy
  • Beijing Tri-Prime Genetic Engineering Co., Ltd.

You can easily book an appointment with one online.

  • Biopharmaceutical
  • Pharmaceutical
  • China
  • Market Size
  • Kyowa Hakko Kirin Co., Ltd.
  • Key news
  • Market landscape

The company manufactures and markets biopharmaceuticals.

  • Biopharmaceutical
  • China
  • World
  • Forecast
  • Kyowa Hakko Kirin Co., Ltd.

RCC Market Patent Trend by Top Inventors Merck ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer ## ## ## ## ## ## ## ## ## ## ## ## ## ## Roche ## ## ## ## ## ## ## ## ## ## ## ## ## ## NIH ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Genentech ## ## ## ## ## ## ## ## ##

  • Biopharmaceutical
  • Cancer
  • Renal Cancer
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.

Arthritis Research Therapy; ##(##): ##-## Bridges D, et al. (2001).

  • Biopharmaceutical
  • Blood Disease
  • Cancer
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.

TS-## (tegafur, gimeracil, oteracil) ##.

  • Biopharmaceutical
  • North America
  • United States
  • Demand
  • Kyowa Hakko Kirin Co., Ltd.
  • 6. Profiles of Anti-CD123 Immunotherapeutics

Seattle Genetics has licensed its auristatin- and PBD-based ADC technology to a number of biopharmaceutical companies.

  • Biopharmaceutical
  • Immunotherapy
  • Cellectis S.A.
  • Janssen Biotech, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • ENGINEERED ANTIBODIES

CTI BIOPHARMA ##.

  • Biopharmaceutical
  • North America
  • United States
  • Forecast
  • Kyowa Hakko Kirin Co., Ltd.

Antibody Cancer ## ## ID No.

  • Biopharmaceutical
  • Biosimilar
  • Biogen Idec Inc.
  • Boehringer Ingelheim GmbH
  • Kyowa Hakko Kirin Co., Ltd.
  • KYOWA HAKKO KIRIN ENTERS INTO AGREEMENT WITH ASTRAZENECA
  • DEC 01, 2017: FARON PHARMACEUTICALS OY: APPOINTMENT OF CHIEF COMMERCIAL OFFICER

Article ##.

  • Biopharmaceutical
  • Pharmaceutical
  • Japan
  • United States
  • Kyowa Hakko Kirin Co., Ltd.
  • Oct 27, 2017: Kyowa Hakko Kirin Announces Marketing Authorization Application for Mogamulizumab Validated by European Medicines Agency

The molecules developed by companies in Pre- Registration, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Biopharmaceutical
  • Lymphoma
  • Protein Therapy
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.

The molecules developed by companies in Pre-Registration, Phase II, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Biopharmaceutical
  • Lymphoma
  • Protein Therapy
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.
  • Vendor landscape

You can easily book an appointment with one online.

  • Biopharmaceutical
  • Pharmaceutical
  • Chugai Pharmaceutical Co., Ltd.
  • Kissei Pharmaceutical Co., Ltd.
  • Kyowa Hakko Kirin Co., Ltd.

The molecules developed by companies in Pre-Registration, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Biopharmaceutical
  • Lymphoma
  • Protein Therapy
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.

BioWa is a biopharmaceutical company, while NKTT is a biotechnology company.

  • Biopharmaceutical
  • Pharmaceutical
  • Therapy
  • Company
  • Kyowa Hakko Kirin Co., Ltd.

Romiplate is biopharmaceutical product designated as an orphan drug in February, 2010.

  • Biopharmaceutical
  • Monoclonal Antibody
  • Research And Development
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.